Eagle Veterinary Technology Co.,Ltd (KOSDAQ:044960)
South Korea · Delayed Price · Currency is KRW 4,385.00
+40.00 (0.92%)
At close: Feb 13, 2026
KOSDAQ:044960 Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 42,510 | 41,717 | 42,794 | 43,540 | 40,437 | 40,357 |
Other Revenue | -0 | -0 | -0 | - | - | 0 |
| 42,510 | 41,717 | 42,794 | 43,540 | 40,437 | 40,357 | |
Revenue Growth (YoY) | 2.26% | -2.52% | -1.71% | 7.67% | 0.20% | 17.24% |
Cost of Revenue | 28,349 | 27,807 | 28,355 | 28,851 | 26,210 | 28,281 |
Gross Profit | 14,161 | 13,910 | 14,438 | 14,689 | 14,227 | 12,076 |
Selling, General & Admin | 9,705 | 9,091 | 9,549 | 9,808 | 8,439 | 7,294 |
Research & Development | 555.41 | 354.8 | 295.27 | 127.34 | 139.56 | 128.79 |
Amortization of Goodwill & Intangibles | 38.16 | 39.52 | 39.76 | 38.6 | 35.06 | 43.42 |
Other Operating Expenses | 59.34 | 71.02 | 56.93 | 95.65 | 18.83 | 15.07 |
Operating Expenses | 10,484 | 10,453 | 11,123 | 11,280 | 10,709 | 8,656 |
Operating Income | 3,677 | 3,457 | 3,315 | 3,409 | 3,518 | 3,419 |
Interest Expense | -266.89 | -320.38 | -299.92 | -232.75 | -138.08 | -179.16 |
Interest & Investment Income | 178.58 | 168.47 | 298.22 | 174.42 | 99.1 | 85.74 |
Earnings From Equity Investments | -98.29 | 26.31 | 83.62 | 26.35 | 194.61 | 75.62 |
Currency Exchange Gain (Loss) | 504.92 | 1,070 | 28.06 | 273.53 | 361.71 | -480.19 |
Other Non Operating Income (Expenses) | 57.89 | 81.38 | 30.3 | -140.46 | -84.77 | -174.8 |
EBT Excluding Unusual Items | 4,053 | 4,483 | 3,455 | 3,510 | 3,951 | 2,747 |
Gain (Loss) on Sale of Investments | 150.27 | -75.97 | 63.71 | 22.37 | 4.61 | 9.62 |
Gain (Loss) on Sale of Assets | -56.88 | 6.18 | -9.16 | 16.83 | 14.26 | 13.37 |
Asset Writedown | - | - | - | -120.65 | -94.05 | -0.14 |
Other Unusual Items | - | - | - | - | - | 159.81 |
Pretax Income | 4,146 | 4,413 | 3,520 | 3,429 | 3,875 | 2,929 |
Income Tax Expense | 459.97 | 707.5 | 543.61 | 785.44 | 237.55 | 470.49 |
Net Income | 3,686 | 3,705 | 2,976 | 2,643 | 3,638 | 2,459 |
Net Income to Common | 3,686 | 3,705 | 2,976 | 2,643 | 3,638 | 2,459 |
Net Income Growth | 38.31% | 24.51% | 12.58% | -27.34% | 47.95% | 99.53% |
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | 12 |
EPS (Basic) | 300.33 | 301.86 | 242.44 | 215.35 | 296.36 | 200.31 |
EPS (Diluted) | 300.33 | 301.86 | 242.44 | 215.35 | 296.36 | 200.31 |
EPS Growth | 38.31% | 24.51% | 12.58% | -27.34% | 47.95% | 99.53% |
Free Cash Flow | 5,010 | 2,562 | 364.38 | -705.21 | 5,948 | 5,113 |
Free Cash Flow Per Share | 408.16 | 208.70 | 29.68 | -57.45 | 484.55 | 416.57 |
Gross Margin | 33.31% | 33.34% | 33.74% | 33.74% | 35.18% | 29.92% |
Operating Margin | 8.65% | 8.29% | 7.75% | 7.83% | 8.70% | 8.47% |
Profit Margin | 8.67% | 8.88% | 6.95% | 6.07% | 9.00% | 6.09% |
Free Cash Flow Margin | 11.79% | 6.14% | 0.85% | -1.62% | 14.71% | 12.67% |
EBITDA | 5,081 | 4,868 | 4,501 | 4,653 | 4,988 | 5,369 |
EBITDA Margin | 11.95% | 11.67% | 10.52% | 10.69% | 12.34% | 13.30% |
D&A For EBITDA | 1,404 | 1,411 | 1,186 | 1,244 | 1,470 | 1,950 |
EBIT | 3,677 | 3,457 | 3,315 | 3,409 | 3,518 | 3,419 |
EBIT Margin | 8.65% | 8.29% | 7.75% | 7.83% | 8.70% | 8.47% |
Effective Tax Rate | 11.09% | 16.03% | 15.45% | 22.91% | 6.13% | 16.06% |
Advertising Expenses | - | 655.45 | 840.73 | 677.74 | 670.82 | 602.66 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.